Potential Benefits of Sonic Augmentation Technology in Music

NCT07065227 · Status: SUSPENDED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2025-10-28

No results posted yet for this study

Summary

The goal of this clinical trial is to explore possible benefits and mechanisms through which listening to music enhanced with Sonic Augmentation Technology (SAT) can improve health and wellness. The main goals of the study are:

* To examine the immediate effects of listening to the augmented music.
* To identify individual characteristics that influence the immediate effects of listening to the augmented music.

Participants will:

* Complete the online pre- and post-surveys.
* Provide pre- and post- music saliva samples (1.5mL).
* Listen to the full 15-minutes music session via over-ear headphones.

Conditions

  • Biobehavioral State
  • Sonic Augmentation Technology
  • Oxytocin
  • Autonomic Reactivity

Interventions

BEHAVIORAL

Augmented Theme

The music is augmented by embedding the natural rhythms of bodily functions (e.g. breathing, heart rate variability, vascular tone, etc) that signal the body to calm.

BEHAVIORAL

Mozart Theme

The selected Mozart composition consists of: Composition Eine kleine Nachtmusik, K. 525 (5 minutes 30 seconds), Andante from Piano Concerto No. 21, K. 467 (6 minutes 30 seconds), and Ave verum corpus, K. 618 (3 minutes).

Sponsors & Collaborators

  • University of Florida

    lead OTHER

Principal Investigators

  • Lourdes P. Dale, PhD · University of Florida

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
89 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-09-24
Primary Completion
2026-05-10
Completion
2026-05-10

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07065227 on ClinicalTrials.gov